Maternal-Fetal Medicine Fellowship
Geisinger’s Maternal-Fetal Medicine Fellowship program immerses you in a high-volume practice, where you’ll see a diverse patient population.
About the program
Helping patients have successful pregnancies and providing healthy starts for newborns is one of the most rewarding paths a physician can follow.
If you’d like to join a team that’s committed to providing the best, most compassionate clinical care — and dedicated to training the next generation of specialists in a collegial, collaborative atmosphere — Geisinger’s three-year Maternal-Fetal Medicine Fellowship could be a good fit for you.
The Geisinger Maternal-Fetal Medicine (MFM) Division includes six fellowship-trained, board-certified faculty perinatologists and a team of MFM nurse practitioners, perinatal ultrasonographers and dedicated genetic counselors and nursing and support staff.
From day one, we’ll treat you as a valued colleague and nurture your journey through our ACGME-accredited program, which has been training maternal-fetal medicine specialists since 2006.
As our Maternal-Fetal Medicine program fellow, you’ll be prepared to excel in a clinical setting and to conduct research that will support the advancement of this constantly evolving, challenging field.
Your training will be immersive and broad. Geisinger’s Maternal-Fetal Medicine Division, located in a region with rural communities and two urban centers, sees a large, diverse patient population.
We have several outpatient offices, including our primary clinics in Danville, Scranton and Forty Fort, Pa. These sites feature on-site antenatal testing units. And each year, we perform more than 5,000 Level II fetal anatomy assessments and over 5,000 fetal growth assessments.
You’ll also train at Geisinger Medical Center, our flagship hospital and research center, where each year we perform about 1,900 deliveries, many of which are high-acuity perinatal transfers. And you’ll work with our team at Geisinger Wyoming Valley Medical Center, where we also deliver about 1,900 babies each year.
The Geisinger system also includes:
- A state-of-the-art birthing center at Geisinger Community Medical Center in Scranton, Pa.
- A Level IV NICU in Geisinger Janet Weis Children’s Hospital at Geisinger Medical Center
- A Level III NICU at Geisinger Wyoming Valley Medical Center
If you’re looking for a maternal-fetal medicine fellowship that will prepare you for leadership in the field, encourage you as a lifelong learner and introduce you to colleagues who will serve as partners during and long after your training, apply to join us.
Program Overview
Our Maternal-Fetal Medicine Fellowship program will provide you with a comprehensive education in the field of perinatal medicine using a curriculum rooted in didactic education, clinical experience and research training.
During your three years with us, you’ll complete rotations in:
- Ultrasound
- Genetics and genomics
- Our outpatient clinic
- Consultative care, including inpatient
- Labor and delivery
- Adult intensive care
- Elective topics
You’ll also gain experience interacting with pathology, anesthesiology and the neonatal intensive care units.
Our approach to care is multidisciplinary and patient-focused. We believe the best doctors aren’t just great clinicians. They understand how to communicate with their patients, empathize and understand each person’s unique life circumstances.
That’s why we offer our fellows a unique opportunity to be involved in multidisciplinary patient counseling with the patient, their family and other health professionals from specialties such as neonatal intensive care, obstetrics, pediatric cardiology, pediatric neurosurgery and pediatric surgery.
During this session, the team — including the patient and their family — will review recommendations for antepartum, labor and delivery, and postpartum management. This includes discussing the expected prognosis for the child and postnatal procedures for appropriate infants, such as those with congenital anomalies. These conferences are an opportunity for multidisciplinary collaboration, and they’re unique in including the patient. Fellows see this as a valuable opportunity to learn about team collaboration, continuity of care and sensitive, effective communication.
Geisinger has a strong tradition of research and innovation, and your fellowship will be rounded out with at least 12 months of dedicated research training.
Research
For up-to-date lists, visit:
- Mackeen AD, Quinn S, Movva V, Berghella V, Ananth CV. Intracervical balloon catheter for labor induction after rupture of membranes: a systematic review and meta-analysis. Am J Obstet Gynecol, 2021 Jun.
- King LJ, Mackeen AD, Nordberg C, Paglia MJ. Maternal risk factors associated with persistent placenta previa, Placenta, Symons Downs D, Pauley AM, Leonard KS, Satti M, Cumbo N, Teti I, Stephens M, Corr T, Roeser R, Deimling T, Legro RS, Pauli JM, Mackeen AD, & Bailey Davis L. Obstetric physicians’ beliefs and knowledge on guidelines and screening tools to reduce opioid use after childbirth. Obstet Gynecol, 2021 Feb 1.
- Mackeen AD, Young AJ, Hetherington V, Lutcher S, Mowery J, Symons Downs D; Bailey-Davis L. Encouraging appropriate gestational weight gain in high-risk gravida: a randomized controlled trial. Obesity Science & Practice, 2021.
- Sullivan M, Cunningham K, Angras K, Mackeen AD. Duration of postpartum magnesium sulfate for seizure prophylaxis in women with preeclampsia: a systematic review and meta-analysis. J Matern Fetal Neonatal Med, 2021.
- Strassberg ER, Fisher SM, Mackeen AD, Sun H and Paglia MJ. Comparison of Different Methods of Patient Education on Preeclampsia: A Randomized Controlled Trial. J Matern Fetal Neonatal Med, 2020 Jul 6;1-5.
- Khalifeh A, Fleisher J, Gressel G, Berghella V, Leiby B, Mackeen AD. Patient preferences for method of cesarean skin closure: secondary outcomes from a randomized trial. J Matern Fetal Neonatal Med, 2020 Feb.
- Strassberg E; Schuster Meike; Rajaram A; Paglia MJ; Neubert AG; Ross JW; Sun H; Mackeen AD. Comparing diagnosis, management and outcomes of fetal growth restriction using different growth curves. J Ultrasound Med, 2019.
- Power ML, Lott ML, Mackeen AD, DiBari J, Schulkin J. Associations between maternal body mass index, gestational weight gain, maternal complications, and birth outcome in singleton, term births in a largely non-Hispanic white, rural population. J Women's Health, 2019 Apr.
- Ross JW, Betz A, Paglia MJ, Feng W, Neubert AG, Mackeen AD. Short- and long-term growth as a function of abnormal Doppler flow in growth-restricted fetuses. Prenatal Cardiology, 2019 Dec 31; 8(1): 76-79.
- Power ML, Gaspar-Oishi M, Gibson K, Kelly L, Lott ML, Mackeen AD, Overcash R, Rhoades C, Turrentine M, Yamamura Y, Schulkin J. A survey of women and their providers regarding gestational weight gain. J Women’s Health, 2019 Apr 30. [E pub ahead of print]. PMID: 31038383.
- Mackeen AD, Ross JW, Betz A, Bringman JJ, Feng W, Paglia MJ. Interartery discordance in fetuses with growth restriction. Prenatal Cardiology, 2018. [In press].
- Rajaram AM, Strassberg ER, Paglia MJ, et al. Comparing Diagnosis, Management, and Outcomes of Fetal Growth Restriction Using Hadlock vs. Fenton Growth Curves [14OP]. Obstetrics & Gynecology. 2017;129 Suppl 1:5S-5S.
- Strassberg ER, Rajaram AM, Neubert AG, et al. 132: Comparing diagnosis, management and outcomes of fetal growth restriction on two different growth curves. AJOG. 2017; 216:S92.
- Reed MJ, Schuster M, Strassberg ER. Preeclampsia, Eclampsia and HELLP Syndrome. In: Hyzy RC, ed. Hyzy’s Evidence Based Critical Care: A Case Study Approach. 1st ed. New York, NY: Springer
- Strassberg ER, Power M, Stark L, Schulkin J, Paglia MJ. Patient Attitudes Toward Influenza and Tdap Vaccination in Pregnancy. Obstetrics & Gynecology. 2016; 127 58S
- Schuster M, Madueke-Laveaux OS, Mackeen AD, Feng W, Paglia MJ. The effect of the MFM obesity protocol on cesarean delivery rates. AJOG, 2016 Oct;
- Schuster M, Jaramillo L, Wild J, Mackeen AD, Paglia MJ. The impact of minor trauma on pregnancy and neonatal outcomes. Trauma, 2016.
- Schuster M, Mackeen DA. Fetal Endometriosis: a case report. Fertility and Sterility. 2015 Jan: 103(1): 160-2.
- Mackeen AD, Packard RE, Schuster M, Ross JW. Oral Prostaglandin E2 for induction of labour. Cochrane Database Syst. Rev. 2015.
Frequently asked questions
About Geisinger
Geisinger serves more than 1 million people in central and northeast Pennsylvania. We’ve been nationally recognized for innovative practices in quality, delivery models such as ProvenCare® and the use of an award-winning electronic medical record, Epic®. Our physician-led system has about 24,000 employees, including nearly 1,700 physicians, 10 hospital campuses, two research centers and a health plan with more than half a million members, all of which boost our hometown economies by $7.1 billion annually.
Location
Danville, Pa., is a unique and wonderful place to train. Opportunities for outdoor recreation are endless, the cost of living is low and traffic is almost nonexistent. We’re also close enough to Philadelphia, New York City and Washington, D.C., to make weekend getaways easy.